Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Pfister

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Medical Journal|February 5, 1972
Cerebrotendinous xanthomatosisA S Truswell, P J Pfister
Molecular Pharmacology|April 17, 2008
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expressionN Ferri, A Granata, C Pirola, et al.
The Laryngoscope|October 14, 2005
Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled studyD W Kennedy, F A Kuhn, D L Hamilos, et al.
European Heart Journal|March 13, 1999
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trialP W Serruys, D P Foley, G Jackson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Medical Journal|February 5, 1972
Cerebrotendinous xanthomatosisA S Truswell, P J Pfister
Molecular Pharmacology|April 17, 2008
Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expressionN Ferri, A Granata, C Pirola, et al.
The Laryngoscope|October 14, 2005
Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled studyD W Kennedy, F A Kuhn, D L Hamilos, et al.
European Heart Journal|March 13, 1999
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trialP W Serruys, D P Foley, G Jackson, et al.
Pageof 1